AustralieFrV1, Main, Exploration, bibRecord, 006836

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

Identifieur interne : 006836 ( Main/Exploration ); précédent : 006835; suivant : 006837

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

Auteurs : M. Pirmohamed [Royaume-Uni] ; P. S. Friedmann [Royaume-Uni] ; M. Molokhia [Royaume-Uni] ; Y. K. Loke [Royaume-Uni] ; C. Smith [Royaume-Uni] ; E. Phillips [Australie] ; L. La Grenade [États-Unis] ; B. Carleton [Canada] ; M. Papaluca-Amati [Royaume-Uni] ; P. Demoly [France] ; N. H. Shear [Canada]

Source :

Clinical pharmacology and therapeutics [ 0009-9236 ] ; 2011.

RBID : Pascal:11-0282085

Descripteurs français

Pascal (Inist)
- Phénotype, Normalisation, Système immunitaire, Médicament, Toxicité, Peau, Homme.
Wicri :
- topic : Normalisation, Médicament, Homme.

English descriptors

KwdEn :
- Drug, Human, Immune system, Phenotype, Skin, Standardization, Toxicity.

Abstract

Advances in genetic research and molecular biology techniques have made it possible to begin to characterize the underlying genetic factors that predispose patients to serious forms of drug-induced skin injury (DISI).To facilitate research in this area, we have set out standardized phenotypic definitions for (i) Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), (ii) acute generalized exanthematous pustulosis (AGEP), and (iii) hypersensitivity syndrome (HSS; also known as drug reaction with eosinophilia and systemic symptoms (DRESS) and drug-induced hypersensitivity syndrome (DIHS)). A DISI Expert Working Group comprising participants with varied expertise reviewed and debated current terminology and diagnostic criteria for DISI and agreed on the minimum phenotypic criteria for selected forms of DISI (SJS/ TEN, AGEP, and HSS). In addition, an algorithm has been developed to aid appropriate clinical categorization of patients with DISI.These standardized criteria will be important in facilitating adequate and accurate patient recruitment in order to advance research in pharmacogenomic, immunological, mechanistic, and epidemiological studies.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 001C47
to stream PascalFrancis, to step Curation: 004296
to stream PascalFrancis, to step Checkpoint: 001798
to stream Main, to step Merge: 006C49
to stream Main, to step Curation: 006836

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury</title>
<author><name sortKey="Pirmohamed, M" sort="Pirmohamed, M" uniqKey="Pirmohamed M" first="M." last="Pirmohamed">M. Pirmohamed</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Wolfson Centre for Personalised Medicine, University of Liverpool</s1>
<s2>Liverpool</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Friedmann, P S" sort="Friedmann, P S" uniqKey="Friedmann P" first="P. S." last="Friedmann">P. S. Friedmann</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Infection, Inflammation & Immunity Division, School of Medicine, University of Southampton</s1>
<s2>Southampton</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Southampton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Molokhia, M" sort="Molokhia, M" uniqKey="Molokhia M" first="M." last="Molokhia">M. Molokhia</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>London School of Hygiene and Tropical Medicine</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Loke, Y K" sort="Loke, Y K" uniqKey="Loke Y" first="Y. K." last="Loke">Y. K. Loke</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>University of East Anglia</s1>
<s2>Norwich</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>University of East Anglia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Smith, C" sort="Smith, C" uniqKey="Smith C" first="C." last="Smith">C. Smith</name>
<affiliation wicri:level="3"><inist:fA14 i1="05"><s1>St John's Institute of Dermatology, Guys and StThomas'FoundationTrust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Phillips, E" sort="Phillips, E" uniqKey="Phillips E" first="E." last="Phillips">E. Phillips</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Murdoch University and University of Western Australia, Sir Charles Gairdner Hospital and Royal Perth Hospital</s1>
<s2>Perth</s2>
<s3>AUS</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="La Grenade, L" sort="La Grenade, L" uniqKey="La Grenade L" first="L." last="La Grenade">L. La Grenade</name>
<affiliation wicri:level="2"><inist:fA14 i1="07"><s1>Food and Drug Administration</s1>
<s2>Silver Spring, Maryland</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Carleton, B" sort="Carleton, B" uniqKey="Carleton B" first="B." last="Carleton">B. Carleton</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Pharmaceutical Outcomes Programme, University of British Columbia</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Papaluca Amati, M" sort="Papaluca Amati, M" uniqKey="Papaluca Amati M" first="M." last="Papaluca-Amati">M. Papaluca-Amati</name>
<affiliation wicri:level="3"><inist:fA14 i1="09"><s1>European Medicines Agency</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Demoly, P" sort="Demoly, P" uniqKey="Demoly P" first="P." last="Demoly">P. Demoly</name>
<affiliation wicri:level="3"><inist:fA14 i1="10"><s1>Allergy Department-INSERM U657-Hopital Arnaud de Villeneuve, University Hospital of Montpellier</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shear, N H" sort="Shear, N H" uniqKey="Shear N" first="N. H." last="Shear">N. H. Shear</name>
<affiliation wicri:level="4"><inist:fA14 i1="11"><s1>University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0282085</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0282085 INIST</idno>
<idno type="RBID">Pascal:11-0282085</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001C47</idno>
<idno type="wicri:Area/PascalFrancis/Curation">004296</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001798</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001798</idno>
<idno type="wicri:doubleKey">0009-9236:2011:Pirmohamed M:phenotype:standardization:for</idno>
<idno type="wicri:Area/Main/Merge">006C49</idno>
<idno type="wicri:Area/Main/Curation">006836</idno>
<idno type="wicri:Area/Main/Exploration">006836</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury</title>
<author><name sortKey="Pirmohamed, M" sort="Pirmohamed, M" uniqKey="Pirmohamed M" first="M." last="Pirmohamed">M. Pirmohamed</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Wolfson Centre for Personalised Medicine, University of Liverpool</s1>
<s2>Liverpool</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Friedmann, P S" sort="Friedmann, P S" uniqKey="Friedmann P" first="P. S." last="Friedmann">P. S. Friedmann</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Infection, Inflammation & Immunity Division, School of Medicine, University of Southampton</s1>
<s2>Southampton</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Southampton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Molokhia, M" sort="Molokhia, M" uniqKey="Molokhia M" first="M." last="Molokhia">M. Molokhia</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>London School of Hygiene and Tropical Medicine</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Loke, Y K" sort="Loke, Y K" uniqKey="Loke Y" first="Y. K." last="Loke">Y. K. Loke</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>University of East Anglia</s1>
<s2>Norwich</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>University of East Anglia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Smith, C" sort="Smith, C" uniqKey="Smith C" first="C." last="Smith">C. Smith</name>
<affiliation wicri:level="3"><inist:fA14 i1="05"><s1>St John's Institute of Dermatology, Guys and StThomas'FoundationTrust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Phillips, E" sort="Phillips, E" uniqKey="Phillips E" first="E." last="Phillips">E. Phillips</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Murdoch University and University of Western Australia, Sir Charles Gairdner Hospital and Royal Perth Hospital</s1>
<s2>Perth</s2>
<s3>AUS</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="La Grenade, L" sort="La Grenade, L" uniqKey="La Grenade L" first="L." last="La Grenade">L. La Grenade</name>
<affiliation wicri:level="2"><inist:fA14 i1="07"><s1>Food and Drug Administration</s1>
<s2>Silver Spring, Maryland</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Carleton, B" sort="Carleton, B" uniqKey="Carleton B" first="B." last="Carleton">B. Carleton</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Pharmaceutical Outcomes Programme, University of British Columbia</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Papaluca Amati, M" sort="Papaluca Amati, M" uniqKey="Papaluca Amati M" first="M." last="Papaluca-Amati">M. Papaluca-Amati</name>
<affiliation wicri:level="3"><inist:fA14 i1="09"><s1>European Medicines Agency</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Demoly, P" sort="Demoly, P" uniqKey="Demoly P" first="P." last="Demoly">P. Demoly</name>
<affiliation wicri:level="3"><inist:fA14 i1="10"><s1>Allergy Department-INSERM U657-Hopital Arnaud de Villeneuve, University Hospital of Montpellier</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shear, N H" sort="Shear, N H" uniqKey="Shear N" first="N. H." last="Shear">N. H. Shear</name>
<affiliation wicri:level="4"><inist:fA14 i1="11"><s1>University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Clinical pharmacology and therapeutics</title>
<title level="j" type="abbreviated">Clin. pharmacol. ther.</title>
<idno type="ISSN">0009-9236</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Clinical pharmacology and therapeutics</title>
<title level="j" type="abbreviated">Clin. pharmacol. ther.</title>
<idno type="ISSN">0009-9236</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Drug</term>
<term>Human</term>
<term>Immune system</term>
<term>Phenotype</term>
<term>Skin</term>
<term>Standardization</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Phénotype</term>
<term>Normalisation</term>
<term>Système immunitaire</term>
<term>Médicament</term>
<term>Toxicité</term>
<term>Peau</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Normalisation</term>
<term>Médicament</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Advances in genetic research and molecular biology techniques have made it possible to begin to characterize the underlying genetic factors that predispose patients to serious forms of drug-induced skin injury (DISI).To facilitate research in this area, we have set out standardized phenotypic definitions for (i) Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), (ii) acute generalized exanthematous pustulosis (AGEP), and (iii) hypersensitivity syndrome (HSS; also known as drug reaction with eosinophilia and systemic symptoms (DRESS) and drug-induced hypersensitivity syndrome (DIHS)). A DISI Expert Working Group comprising participants with varied expertise reviewed and debated current terminology and diagnostic criteria for DISI and agreed on the minimum phenotypic criteria for selected forms of DISI (SJS/ TEN, AGEP, and HSS). In addition, an algorithm has been developed to aid appropriate clinical categorization of patients with DISI.These standardized criteria will be important in facilitating adequate and accurate patient recruitment in order to advance research in pharmacogenomic, immunological, mechanistic, and epidemiological studies.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>Canada</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
<li>Languedoc-Roussillon</li>
<li>Maryland</li>
<li>Occitanie (région administrative)</li>
<li>Ontario</li>
</region>
<settlement><li>Londres</li>
<li>Montpellier</li>
<li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Pirmohamed, M" sort="Pirmohamed, M" uniqKey="Pirmohamed M" first="M." last="Pirmohamed">M. Pirmohamed</name>
</noRegion>
<name sortKey="Friedmann, P S" sort="Friedmann, P S" uniqKey="Friedmann P" first="P. S." last="Friedmann">P. S. Friedmann</name>
<name sortKey="Loke, Y K" sort="Loke, Y K" uniqKey="Loke Y" first="Y. K." last="Loke">Y. K. Loke</name>
<name sortKey="Molokhia, M" sort="Molokhia, M" uniqKey="Molokhia M" first="M." last="Molokhia">M. Molokhia</name>
<name sortKey="Papaluca Amati, M" sort="Papaluca Amati, M" uniqKey="Papaluca Amati M" first="M." last="Papaluca-Amati">M. Papaluca-Amati</name>
<name sortKey="Smith, C" sort="Smith, C" uniqKey="Smith C" first="C." last="Smith">C. Smith</name>
</country>
<country name="Australie"><noRegion><name sortKey="Phillips, E" sort="Phillips, E" uniqKey="Phillips E" first="E." last="Phillips">E. Phillips</name>
</noRegion>
</country>
<country name="États-Unis"><region name="Maryland"><name sortKey="La Grenade, L" sort="La Grenade, L" uniqKey="La Grenade L" first="L." last="La Grenade">L. La Grenade</name>
</region>
</country>
<country name="Canada"><noRegion><name sortKey="Carleton, B" sort="Carleton, B" uniqKey="Carleton B" first="B." last="Carleton">B. Carleton</name>
</noRegion>
<name sortKey="Shear, N H" sort="Shear, N H" uniqKey="Shear N" first="N. H." last="Shear">N. H. Shear</name>
</country>
<country name="France"><region name="Occitanie (région administrative)"><name sortKey="Demoly, P" sort="Demoly, P" uniqKey="Demoly P" first="P." last="Demoly">P. Demoly</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006836 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006836 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:11-0282085
   |texte=   Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri